Burlington Stores (BURL) Jumps 14.52% on January 12

Equities Staff |

Burlington Stores (BURL) was among the biggest gainers on the Russell 2000 for Tuesday January 12 as the stock popped 14.52% to $48.97, representing a gain of $6.21 per share. Some 5.57 million shares traded hands on 38,976 trades, compared with an average daily volume of 1.4 million shares out of a total float of 75.95 million. The stock opened at $48.29 and traded with an intraday range of $49.08 to $47.19.

After today's gains, Burlington Stores reached a market cap of $3.72 billion. Burlington Stores has had a trading range between $61.94 and $39.40 over the last year, and it had a 50-day SMA of $44.72 and a 200-day SMA of $50.93.

The stock has a P/E Ratio of 14.7.

Burlington Stores Inc is a retailer of apparel at everyday low prices It offers customers apparel, including ladies sportswear, menswear, coats, and family footwear, as well as baby furniture, accessories, home décor and gifts.

Burlington Stores is based out of Burlington, NJ and has some 34,000 employees. Its CEO is Thomas A. Kingsbury.

For a complete fundamental analysis analysis of Burlington Stores, check out Equities.com’s Stock Valuation Analysis report for BURL. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.



DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Comments

Emerging Growth

Immunovaccine Inc.

Immunovaccine Inc is clinical stage biopharmaceutical company. The Company develops products based on its proprietary vaccine enhancement platform in T cell activating therapies for cancer.

Private Markets

iPRO Network, LLC

We provide the platform, tools, and resources to empower individuals and professionals to market desirable goods and services to the public, taking the place of traditional methods of commerce.

The Green Organic Dutchman

The Green Organic Dutchman Ltd. ("TGOD") produces farm grown, organic cannabis for medical use. The company grows its high quality organic cannabis in small batches using craft growing, all natural…